ArticleFrontiers in immunology2025
Evaluation of whole blood CD64 for identifying infection in neonates receiving hospital care.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Infection remains one of the most common causes of death in neonates. However, early detection of neonatal infections to inform treatment decisions remains clinically and technically challenging due to the non-specific nature of symptoms, and the lack of a sufficiently accurate diagnostic test. Neonatal infections and sepsis in adults have been associated with increased CD64 expression on neutrophils. We investigated whole blood CD64 (wbCD64) and neutrophil elastase (NE) in neonates who were evaluated and treated for potential infection and evaluated the potential for these biomarkers as diagnostic tools. Methods: Neonates were prospectively recruited from two neonatal units. Whole blood samples were collected at the time of clinical evaluation for potential infection, if antimicrobials were also initiated. Whole blood CD64 and NE, as a marker of the neutrophil count, were measured by enzyme-linked immunosorbent assays (ELISA). Correlations between wbCD64, NE, and standard hematologic indices were evaluated and diagnostic performance of wbCD64 in relation to infections analyzed using logistic regression and receiver operating characteristic (ROC) curves. Results: Samples were analyzed from a total of 178 episodes of infection evaluation from 163 neonates. Whole blood CD64 and NE had a positive, non-linear correlation. Infection was diagnosed in 45% (80/178) of episodes, and 31% (55/178) had infection that was microbiologically confirmed. There was no association identified between wbCD64 and infections, and wbCD64 had poor diagnostic performance for infection detection. Evaluation of wbCD64 relative to levels of NE did not improve diagnostic performance. WbCD64 levels were significantly higher among a subgroup of neonates aged >48 hours who had microbiologically-confirmed bacterial bloodstream infections (BSI), with optimal sensitivity and specificity for BSI detection 53% and 87% respectively. Conclusion: WbCD64 is generally not significantly associated with infection in neonates, but shows some association with bacterial bloodstream infections. The diagnostic performance of wbCD64, with or without NE, does not afford sufficient diagnostic accuracy to aid antimicrobial therapeutic decisions for neonatal infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.